galantamine and Inflammatory Bowel Diseases

galantamine has been researched along with Inflammatory Bowel Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bahgat, AK; El-Abhar, HS; Wadie, W; Wazea, SA	1

Other Studies

1 other study(ies) available for galantamine and Inflammatory Bowel Diseases

Article	Year
Galantamine anti-colitic effect: Role of alpha-7 nicotinic acetylcholine receptor in modulating Jak/STAT3, NF-κB/HMGB1/RAGE and p-AKT/Bcl-2 pathways. Scientific reports, 2018, 03-23, Volume: 8, Issue:1 Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Galantamine; Inflammatory Bowel Diseases; Janus Kinases; Male; NF-kappa B; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Receptor for Advanced Glycation End Products; Signal Transduction; STAT3 Transcription Factor	2018

Article

Year

Galantamine anti-colitic effect: Role of alpha-7 nicotinic acetylcholine receptor in modulating Jak/STAT3, NF-κB/HMGB1/RAGE and p-AKT/Bcl-2 pathways.

Scientific reports, 2018, 03-23, Volume: 8, Issue:1

Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Galantamine; Inflammatory Bowel Diseases; Janus Kinases; Male; NF-kappa B; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Receptor for Advanced Glycation End Products; Signal Transduction; STAT3 Transcription Factor

2018